Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment

SIMPLE SUMMARY: Muscle-invasive urothelial carcinoma of the bladder (UC) is treated with chemotherapies based on the DNA-damaging drug cisplatin, which only works temporarily due to the development of drug resistance. In this study, we show that it may be possible to overcome such resistances by tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Thy, Sophia, Hommel, Alexandra, Meneceur, Sarah, Bartkowiak, Anna L., Schulz, Wolfgang A., Niegisch, Günter, Hoffmann, Michèle J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002916/
https://www.ncbi.nlm.nih.gov/pubmed/33803654
http://dx.doi.org/10.3390/cancers13061376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002916/
https://www.ncbi.nlm.nih.gov/pubmed/33803654
http://dx.doi.org/10.3390/cancers13061376

Ejemplares similares